{"transactions":[{"id":1572491,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Common Stock","published_at":"2024-03-18T21:40:14.000Z","date":"2023-01-09","kind":"sale","planned":false,"acquired":false,"shares":1003,"price":20.6223,"value":20684.1669,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units."}],"balance_after":104369,"source":{"system":"sec-edgar","filing":"0001415889-24-008316","document":"form4-03182024_090300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924008316/form4-03182024_090300.xml","form_type":"4"}},{"id":1572490,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Common Stock","published_at":"2024-03-18T21:40:14.000Z","date":"2019-09-10","kind":"purchase","planned":false,"acquired":true,"shares":965,"price":10.64,"value":10267.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $10.64, and the range of prices were between $10.20 and $10.8799. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":105372,"source":{"system":"sec-edgar","filing":"0001415889-24-008316","document":"form4-03182024_090300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924008316/form4-03182024_090300.xml","form_type":"4"}},{"id":1659006,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Common Stock","published_at":"2024-02-06T02:10:44.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":847,"price":26.1918,"value":22184.4546,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":104407,"source":{"system":"sec-edgar","filing":"0001415889-24-002756","document":"form4-02062024_020236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924002756/form4-02062024_020236.xml","form_type":"4"}},{"id":1670982,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-01-26T00:10:24.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":8000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-001825","document":"form4-01252024_070106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924001825/form4-01252024_070106.xml","form_type":"4"}},{"id":1670981,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-26T00:10:24.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 23, 2024 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":32000,"derivative":{"exercise_price":26.49,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001415889-24-001825","document":"form4-01252024_070106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924001825/form4-01252024_070106.xml","form_type":"4"}},{"id":1682803,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF DEVELOPMENT OFFICER"}}],"security":"Common Stock","published_at":"2024-01-10T01:25:28.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":1019,"price":28.035,"value":28567.665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":105254,"source":{"system":"sec-edgar","filing":"0001415889-24-000883","document":"form4-01102024_010122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924000883/form4-01102024_010122.xml","form_type":"4"}},{"id":1740888,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-11-16T01:13:15.000Z","date":"2023-11-10","kind":"grant","planned":false,"acquired":true,"shares":434,"price":22.287,"value":9672.558,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 434 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":106273,"source":{"system":"sec-edgar","filing":"0001209191-23-055434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123055434/doc4.xml","form_type":"4"}},{"id":1836455,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-07-05T23:37:54.000Z","date":"2023-07-03","kind":"sale","planned":false,"acquired":false,"shares":1004,"price":25.6466,"value":25749.1864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":105839,"source":{"system":"sec-edgar","filing":"0001209191-23-041338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123041338/doc4.xml","form_type":"4"}},{"id":1884750,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-05-19T20:05:57.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":684,"price":16.9235,"value":11575.674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 684 shares by the Reporting Person on May 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":106843,"source":{"system":"sec-edgar","filing":"0001209191-23-030966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123030966/doc4.xml","form_type":"4"}},{"id":2036330,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T22:46:23.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":38500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares vest one year after January 31, 2023 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":38500,"derivative":{"exercise_price":23.48,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":38500},"source":{"system":"sec-edgar","filing":"0001209191-23-006312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123006312/doc4.xml","form_type":"4"}},{"id":2036329,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-02-02T22:46:23.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":9625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":106159,"source":{"system":"sec-edgar","filing":"0001209191-23-006312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123006312/doc4.xml","form_type":"4"}},{"id":2118084,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-11-15T02:40:20.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":82,"price":17.051,"value":1398.182,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 82 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":96534,"source":{"system":"sec-edgar","filing":"0001209191-22-056887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122056887/doc4.xml","form_type":"4"}},{"id":2273573,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-05-13T01:23:03.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":1454,"price":13.566,"value":19724.964,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 1,454 shares by the Reporting Person on May 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":96452,"source":{"system":"sec-edgar","filing":"0001209191-22-028726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122028726/doc4.xml","form_type":"4"}},{"id":2440177,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-07T21:53:14.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares vest one year after January 6, 2022 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":60000,"derivative":{"exercise_price":15.87,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-002428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122002428/doc4.xml","form_type":"4"}},{"id":2440176,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-01-07T21:53:14.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":94998,"source":{"system":"sec-edgar","filing":"0001209191-22-002428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122002428/doc4.xml","form_type":"4"}},{"id":2512923,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-11-15T21:19:29.000Z","date":"2021-11-10","kind":"grant","acquired":true,"shares":753,"price":13.515,"value":10176.795,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 753 shares by the Reporting Person on November 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":84998,"source":{"system":"sec-edgar","filing":"0001209191-21-064449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121064449/doc4.xml","form_type":"4"}},{"id":2554493,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-10-02T00:00:17.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":961,"price":19.256,"value":18505.016,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of the performance-based restricted stock unit award granted to the Reporting Person on March 9, 2021."}],"balance_after":84245,"source":{"system":"sec-edgar","filing":"0001209191-21-058606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121058606/doc4.xml","form_type":"4"}},{"id":2554492,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-10-02T00:00:17.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares became issuable upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of a performance-based restricted stock unit award on March 9, 2021.  On September 29, 2021, the Compensation Committee certified the achievement of the performance criteria resulting in the vesting of 4,062 shares on September 29, 2021 and 4,063 shares on June 30, 2023."}],"balance_after":85206,"source":{"system":"sec-edgar","filing":"0001209191-21-058606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121058606/doc4.xml","form_type":"4"}},{"id":2716725,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-05-12T21:38:59.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":1259,"price":14.62,"value":18406.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 1,259 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":77081,"source":{"system":"sec-edgar","filing":"0001209191-21-032154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121032154/doc4.xml","form_type":"4"}},{"id":2803406,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-09T00:48:46.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 is being amended to correct the transaction date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares vest one year after January 7, 2021 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":65000,"derivative":{"exercise_price":19.19,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-21-018772","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121018772/doc4a.xml","form_type":"4/A","original_submission_date":"2021-01-11"}},{"id":2911079,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-11T22:27:05.000Z","date":"2020-01-07","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 7, 2021 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":65000,"derivative":{"exercise_price":19.19,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-21-003002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121003002/doc4.xml","form_type":"4"}},{"id":2984084,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-11-12T22:14:55.000Z","date":"2020-11-10","kind":"grant","acquired":true,"shares":822,"price":15.266,"value":12548.652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 822 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":75822,"source":{"system":"sec-edgar","filing":"0001209191-20-058048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919120058048/doc4.xml","form_type":"4"}},{"id":3311750,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":92947,"kind":"person","name":"Longpre Lara","position":1,"cik":"0001780347","reported_name":"Longpre Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-14T22:39:29.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 10, 2020 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":52000,"derivative":{"exercise_price":19.24,"expiration_date":"2030-01-09","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001209191-20-003342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919120003342/doc4.xml","form_type":"4"}}]}